Star Scientific announces patent progress with dietary formulation

Star Scientific (STSI -1%) announces that one of its subsidiaries landed a notice of allowance from the PTO for dietary formulation anatabine citrate.

The notification typically means patent approval is pending.

From other sites
Comments (1)
  • DWD Investing
    , contributor
    Comments (13210) | Send Message
    Scary company to trade.
    12 Sep 2013, 05:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs